According to Layton , we won’t need a CR next year because we will be earning revenue from Dermacann. And yes the registry is tightly held , so when the good news does come , which it will , the share price will explode. Until then , we wait.
CP1 Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held